WallStreetZenWallStreetZen

NASDAQ: MYNZ
Mainz Biomed Nv Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

MYNZ past revenue growth

How has MYNZ's revenue growth performed historically?
Company
69%
Industry
0.12%
Market
17.2%
MYNZ's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MYNZ's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
MYNZ's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

MYNZ earnings and revenue history

Current Revenue
$895.5k
Current Earnings
-$26.3M
Current Profit Margin
-2,936.5%

MYNZ Return on Equity

Current Company
-488%
Current Industry
-24%
Current Market
188%
MYNZ's Return on Equity (-488%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MYNZ announces earnings.

MYNZ Return on Assets

Current Company
-145.8%
Current Industry
6.7%
MYNZ is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MYNZ Return on Capital Employed

Current Company
-412.93%
Current Industry
11.6%
MYNZ's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MYNZ vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MYNZ$895.48k-$24.62M-$26.30M+33.56%N/A
OCX$1.50M-$26.05M-$28.72M+61.80%N/A
DMTK$15.30M-$95.04M-$100.89M+44.33%N/A
TTOO$7.19M-$42.53M-$50.08M-7.29%N/A
PMD$22.10M-$768.00k-$4.15M-12.33%N/A
View Top Diagnostic & Research Stocks

MYNZ earnings dates

Next earnings date
May 13, 2024

Mainz Biomed Nv Earnings & Revenue FAQ

What were MYNZ's earnings last quarter?

On Invalid Date, Mainz Biomed Nv (NASDAQ: MYNZ) reported Q4 2023 earnings per share (EPS) of -$0.24, up 55.56% year over year. Total Mainz Biomed Nv earnings for the quarter were -$5.18 million. In the same quarter last year, Mainz Biomed Nv's earnings per share (EPS) was -$0.54.

If you're new to stock investing, here's how to buy Mainz Biomed Nv stock.

What was MYNZ's earnings growth in the past year?

As of Q2 2024, Mainz Biomed Nv's earnings has grown year over year. Mainz Biomed Nv's earnings in the past year totalled -$26.30 million.

What is MYNZ's earnings date?

Mainz Biomed Nv's earnings date is Invalid Date. Add MYNZ to your watchlist to be reminded of MYNZ's next earnings announcement.

What was MYNZ's revenue last quarter?

On Invalid Date, Mainz Biomed Nv (NASDAQ: MYNZ) reported Q4 2023 revenue of $214.76 thousand up 11.11% year over year. In the same quarter last year, Mainz Biomed Nv's revenue was $193.28 thousand.

What was MYNZ's revenue growth in the past year?

As of Q2 2024, Mainz Biomed Nv's revenue has grown 69% year over year. This is 68.88 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 0.12%. Mainz Biomed Nv's revenue in the past year totalled $895.48 thousand.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.